Related references
Note: Only part of the references are listed.Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Beatrice Eymin
BIOCHEMICAL PHARMACOLOGY (2021)
Sporadic vestibular schwannoma: a molecular testing summary
Katherine Sadler et al.
JOURNAL OF MEDICAL GENETICS (2021)
A deep intronic SMARCB1 variant associated with schwannomatosis
Miriam J. Smith et al.
CLINICAL GENETICS (2020)
NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation
Yanan Yu et al.
ACTA NEUROPATHOLOGICA (2020)
Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1
Magdalena Koczkowska et al.
HUMAN MUTATION (2020)
Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types
Eungu Kang et al.
JOURNAL OF HUMAN GENETICS (2020)
AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3′ splice site mutations outside the canonical AG-dinucleotides
Katharina Wimmer et al.
HUMAN MUTATION (2020)
DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis
Barbara Rivera et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
Stanley Zhou et al.
NATURE COMMUNICATIONS (2020)
Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors
Azadeh Amirnasr et al.
SCIENTIFIC REPORTS (2020)
Transcription and splicing: A two-way street
Michael Tellier et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
Characterising the loss-of-function impact of 5' untranslated region variants in 15,708 individuals
Nicola Whiffin et al.
NATURE COMMUNICATIONS (2020)
Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies
Kailong Li et al.
CANCER DISCOVERY (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes
Alina-Andreea Zimta et al.
FRONTIERS IN ONCOLOGY (2020)
The Polygenic and Monogenic Basis of Blood Traits and Diseases
Dragana Vuckovic et al.
CELL (2020)
Expanded encyclopaedias of DNA elements in the human and mouse genomes
Jill E. Moore et al.
NATURE (2020)
Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas
Alexander Pemov et al.
SCIENTIFIC REPORTS (2020)
The GTEx Consortium atlas of genetic regulatory effects across human tissues
Francois Aguet et al.
SCIENCE (2020)
Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells
Yi-deun Jung et al.
REDOX BIOLOGY (2020)
NAA10 polyadenylation signal variants cause syndromic microphthalmia
Jennifer J. Johnston et al.
JOURNAL OF MEDICAL GENETICS (2019)
Detection of Germline Mutations of the SMARCB1 Gene in a Chinese Family with Intraspinal Schwannomatosis
Yuhui Ding et al.
WORLD NEUROSURGERY (2019)
Intronic CNVs and gene expression variation in human populations
Maria Rigau et al.
PLOS GENETICS (2019)
The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling
Yan Cui et al.
ONCOGENE (2019)
Inhibition of MYC by the SMARCB1 tumor suppressor
April M. Weissmiller et al.
NATURE COMMUNICATIONS (2019)
Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1
Antonia Assunto et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene
D. Gareth Evans et al.
LARYNGOSCOPE (2019)
Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma
Irene Paganini et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
Magdalena Koczkowska et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1
Sarah A. Cumming et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas
Hildegard Kehrer-Sawatzki et al.
HUMAN GENETICS (2018)
Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes
Parisa Sharafi et al.
JOURNAL OF NEUROGENETICS (2018)
Schwannomatosis: a genetic and epidemiological study
D. Gareth Evans et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
Phuc H. Hoang et al.
LEUKEMIA (2018)
Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis
Camille Louvrier et al.
NEURO-ONCOLOGY (2018)
Enhancer Logic and Mechanics in Development and Disease
Ryan Rickels et al.
TRENDS IN CELL BIOLOGY (2018)
Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1
Alessandro Stella et al.
GENES (2018)
Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer
Giulia Orlando et al.
NATURE GENETICS (2018)
Developmental enhancers and chromosome topology
Eileen E. M. Furlong et al.
SCIENCE (2018)
NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer
Patrick S. Dischinger et al.
NPJ BREAST CANCER (2018)
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis
Hildegard Kehrer-Sawatzki et al.
HUMAN GENETICS (2017)
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
Xiaofeng Wang et al.
NATURE GENETICS (2017)
Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis
Miriam J. Smith et al.
NEUROLOGY (2017)
Using high-resolution variant frequencies to empower clinical genome interpretation
Nicola Whiffin et al.
GENETICS IN MEDICINE (2017)
Emerging genotype-phenotype relationships in patients with large NF1 deletions
Hildegard Kehrer-Sawatzki et al.
HUMAN GENETICS (2017)
Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice
Hieu T. Nguyen et al.
HUMAN MOLECULAR GENETICS (2017)
Genetic Severity Score predicts clinical phenotype in NF2
Dorothy Halliday et al.
JOURNAL OF MEDICAL GENETICS (2017)
Recurrent and functional regulatory mutations in breast cancer
Esther Rheinbay et al.
NATURE (2017)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer
Rebecca F. Lowdon et al.
PLOS ONE (2017)
Genetic diagnosis of Mendelian disorders via RNA sequencing
Laura S. Kremer et al.
NATURE COMMUNICATIONS (2017)
Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex
Payel Sen et al.
CELL REPORTS (2017)
Constitutional LZTR1 mutation presenting with a unilateral vestibular schwannoma in a teenager
K. W. Gripp et al.
CLINICAL GENETICS (2017)
First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation
Ramita Dewan et al.
BMC CANCER (2017)
Role of Merlin/NF2 inactivation in tumor biology
A. M. Petrilli et al.
ONCOGENE (2016)
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
Jonathon Torchia et al.
CANCER CELL (2016)
Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer
Swneke D. Bailey et al.
NATURE GENETICS (2016)
High-resolution interrogation of functional elements in the noncoding genome
Neville E. Sanjana et al.
SCIENCE (2016)
Translational control by 5′-untranslated regions of eukaryotic mRNAs
Alan G. Hinnebusch et al.
SCIENCE (2016)
Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only
D. G. Evans et al.
EBIOMEDICINE (2016)
A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy
Joanna Somers et al.
GENES & DEVELOPMENT (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation
Kitiwan Rojnueangnit et al.
HUMAN MUTATION (2015)
Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis
Irene Paganini et al.
HUMAN PATHOLOGY (2015)
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients
Adam Hexter et al.
JOURNAL OF MEDICAL GENETICS (2015)
The role of regulatory variation in complex traits and disease
Frank W. Albert et al.
NATURE REVIEWS GENETICS (2015)
Splicing of many human genes involves sites embedded within introns
Steven Kelly et al.
NUCLEIC ACIDS RESEARCH (2015)
Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation
Ansgar Zoch et al.
PLOS ONE (2015)
Multiple conformations are a conserved and regulatory feature of the RB1 5′ UTR
Katrina M. Kutchko et al.
RNA (2015)
A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma
Zai-Li Luo et al.
NATURE COMMUNICATIONS (2015)
Expanding the mutational spectrum of LZTR1 in schwannomatosis
Irene Paganini et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas
Valentina Pinna et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis
Miriam J. Smith et al.
NEUROLOGY (2015)
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants
Sonja Hutter et al.
ACTA NEUROPATHOLOGICA (2014)
Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing
Weihong Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Neurofibromatosis Type 1 Alternative Splicing Is a Key Regulator of Ras Signaling in Neurons
Melissa N. Hinman et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas
Arkadiusz Piotrowski et al.
NATURE GENETICS (2014)
Genome-wide analysis of noncoding regulatory mutations in cancer
Nils Weinhold et al.
NATURE GENETICS (2014)
A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma
Ilyess Zemmoura et al.
NEURO-ONCOLOGY (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors
Miriam J. Smith et al.
CANCER GENETICS (2014)
Genetic Modifiers of Neurofibromatosis Type 1-Associated Cafe-au-Lait Macule Count Identified Using Multi-platform Analysis
Alexander Pemov et al.
PLOS GENETICS (2014)
Thirty-Nine Novel Neurofibromatosis 1 (NF1) Gene Mutations Identified in Slovak Patients
Martina Nemethova et al.
ANNALS OF HUMAN GENETICS (2013)
In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2
Elisabeth Castellanos et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience
Audrey Sabbagh et al.
HUMAN MUTATION (2013)
A compendium of RNA-binding motifs for decoding gene regulation
Debashish Ray et al.
NATURE (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Screening in silico predicted remotely acting NF1 gene regulatory elements for mutations in patients with neurofibromatosis type 1
Stephen E. Hamby et al.
HUMAN GENOMICS (2013)
Vestibular Schwannomas Occur in Schwannomatosis and Should not be Considered an Exclusion Criterion for Clinical Diagnosis
Miriam J. Smith et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Alternative splicing of the neurofibromatosis type I pre-mRNA
Victoria A. Barron et al.
BIOSCIENCE REPORTS (2012)
Expression of SMARCB1 (INI1) mutations in familial schwannomatosis
Miriam J. Smith et al.
HUMAN MOLECULAR GENETICS (2012)
Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity
Minja Laulajainen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis
Miriam J. Smith et al.
NEUROGENETICS (2012)
An emerging role for microRNAs in NF1 tumorigenesis
Ashni Sedani et al.
HUMAN GENOMICS (2012)
Transcription regulation by distal enhancers Who's in the loop?
Ralph Stadhouders et al.
TRANSCRIPTION-AUSTIN (2012)
Are snoRNAs and snoRNA host genes new players in cancer?
Gwyn T. Williams et al.
NATURE REVIEWS CANCER (2012)
Effects of Splicing Mutations on NF2-Transcripts: Transcript Analysis and Information Theoretic Predictions
James R. Ellis et al.
GENES CHROMOSOMES & CANCER (2011)
A Mild Neurofibromatosis Type 1 Phenotype Produced by the Combination of the Benign Nature of a Leaky NF1-Splice Mutation and the Presence of a Complex Mosaicism
Juana Fernandez-Rodriguez et al.
HUMAN MUTATION (2011)
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset
Miriam J. Smith et al.
JOURNAL OF MEDICAL GENETICS (2011)
A Highly Sensitive Genetic Protocol to Detect NF1 Mutations
Maria Carmen Valero et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
FERM Domain Phosphoinositide Binding Targets Merlin to the Membrane and Is Essential for Its Growth-Suppressive Function
Timmy Mani et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
The NF1 Gene Contains Hotspots for L1 Endonuclease-Dependent De Novo Insertion
Katharina Wimmer et al.
PLOS GENETICS (2011)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Mobile Interspersed Repeats Are Major Structural Variants in the Human Genome
Cheng Ran Lisa Huang et al.
CELL (2010)
Natural Mutagenesis of Human Genomes by Endogenous Retrotransposons
Rebecca C. Iskow et al.
CELL (2010)
Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterations
M. J. Smith et al.
CLINICAL GENETICS (2009)
Low U1 snRNP dependence at the NF1 exon 29 donor splice site
Michela Raponi et al.
FEBS JOURNAL (2009)
Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1
Audrey Sabbagh et al.
HUMAN MOLECULAR GENETICS (2009)
Antisense Therapeutics for Neurofibromatosis Type 1 Caused by Deep Intronic Mutations
Eva Pros et al.
HUMAN MUTATION (2009)
Neurofibromatosis type 2
Ashok R. Asthagiri et al.
LANCET (2009)
The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas
Meena Upadhyaya et al.
NEUROGENETICS (2009)
Neurofibromatosis type 2 (NF2): A clinical and molecular review
D. Gareth R. Evans
ORPHANET JOURNAL OF RARE DISEASES (2009)
Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans
Sarah E. Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas
Sushama Patil et al.
BRAIN PATHOLOGY (2008)
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis
C. Boyd et al.
CLINICAL GENETICS (2008)
The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors
Natasa Skoko et al.
FEBS LETTERS (2008)
Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas
Roberta Sestini et al.
HUMAN MUTATION (2008)
Nature and mRNA Effect of 282 Different NF1 Point Mutations: Focus on Splicing Alterations
Eva Pros et al.
HUMAN MUTATION (2008)
Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis
K. D. Hadfield et al.
JOURNAL OF MEDICAL GENETICS (2008)
Germline mutation of INI1/SMARCB1 in familial schwannomatosis
Theo J. M. Hulsebos et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus
Caisa M. Hansson et al.
BMC GENOMICS (2007)
Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5 ' splice-site disruption
K. Wimmer et al.
HUMAN MUTATION (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
NF1 mRNA biogenesis:: Effect of the genomic milieu in splicing regulation of the NF1 exon 37 region
Marco Baralle et al.
FEBS LETTERS (2006)
Analysis of NF1 transcriptional regulatory elements
TKB Lee et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2005)
Diagnostic criteria for schwannomatosis
M MacCollin et al.
NEUROLOGY (2005)
Multiple meningiomas: differential involvement of the NF2 gene in children and adults
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2005)
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: A population-based study
ME Baser et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Functional analysis of polymorphic variation within the promoter and 5' untranslated region of the neurofibromatosis type 1 (NF1) gene
MP Horan et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Mutation scanning of the NF2 gene: An improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis
AJ Wallace et al.
GENETIC TESTING (2004)
Novel and Recurrent Mutations in the NF1 Gene in Italian Patients with Neurofibromatosis Type 1
Alessandro De Luca et al.
HUMAN MUTATION (2004)
Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1
A Zatkova et al.
HUMAN MUTATION (2004)
NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient
P Colapietro et al.
HUMAN GENETICS (2003)
High frequency of alternative splicing of human genes participating in the HIV-1 life cycle -: A model using TSG101, βTrCP, PPIA, INI1, NAF1, and PML
M Favre et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Strong conservation of the human NF2 locus based on sequence comparison in five species
CM Hansson et al.
MAMMALIAN GENOME (2003)
Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients -: art. no. e82
E Ars et al.
JOURNAL OF MEDICAL GENETICS (2003)
Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens
C Hagel et al.
ACTA NEUROPATHOLOGICA (2002)
Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas
A Mohyuddin et al.
JOURNAL OF MEDICAL GENETICS (2002)
Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study
VF Mautner et al.
JOURNAL OF NEUROSURGERY (2002)
Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts
LS Chang et al.
GENOMICS (2002)
Schwannomin isoform-1 interacts with syntenin via PDZ domains
M Jannatipour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Analysis of the human neurofibromatosis type 2 gene promoter and its expression
DB Welling et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2000)
Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene
R Sestini et al.
HUMAN GENETICS (2000)
Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus
M Sainio et al.
NEUROLOGY (2000)
Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the CAP-related domain
R Fahsold et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
E Ars et al.
HUMAN MOLECULAR GENETICS (2000)
Molecular analysis of the 5 '-flanking region of the neurofibromatosis type 1 (NF1) gene: identification of five sequence variants
M Osborn et al.
CLINICAL GENETICS (2000)
Share Paper
